Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Italy News Dispatch.
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
Press releases published on July 1, 2025

Teledyne Space Imaging CIS120 sensors launch on Japanese GOSAT-GW climate change observation mission
Teledyne Technologies Incorporated (NYSE:TDY) CHELMSFORD, UNITED KINGDOM, July 1, 2025 /EINPresswire.com/ -- Teledyne Technologies Incorporated (NYSE:TDY), a leading provider of advanced imaging solutions, is proud to announce that two CIS120 sensors …

Balfour Capital Group Welcomes Gerald Kotollaku as Investment Advisor
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, July 1, 2025 /EINPresswire.com/ -- Balfour Capital Group is proud to welcome Gerald Kotollaku to its global advisory platform. With a strong record in financial analysis, risk management, …

Balfour Capital Group Welcomes Salvatore Napolitano: Senior Advisor
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, July 1, 2025 /EINPresswire.com/ -- Balfour Capital Group, a leading global boutique investment firm, is pleased to announce the appointment of Salvatore Napolitano as Senior Advisor. With …

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma multiforme (TEM-GBM) study, with 25 patients …